[Edaily Reporter Kwon Oh Seok ] Buying interest continues in LotteNon-LifeInsurance(000400)on the stock market amid rumors of a takeover. According to MP Doctor on the 30th, LotteNon-LifeInsurance was trading at 2,515 won as of 9:04 a.m., up 12.03% from the previous trading day. The stock closed at its daily upper limit the previous day (the 29th). Previously, some media outlets reported that ShinhanFinancialGroup Co.,Ltd. and others were pursuing the acquisition of LotteNon-LifeInsurance. ShinhanFinancialGroup Co.,Ltd. announced in a regulatory filing, “We are reviewing measures to strengthen our non-banking competitiveness, but there are currently no confirmed plans regarding the acquisition of a stake in LotteNon-LifeInsurance.” KOREA INVESTMENT HOLDINGS also recently submitted a letter of intent (LOI) and conducted due diligence on LotteNon-LifeInsurance last year. In this regard, KOREA INVESTMENT HOLDINGS also announced, “We are reviewing the acquisition of LotteNon-LifeInsurance, but nothing has been finalized at this time.”
Lisa Su, Chairwoman and CEO of AMD, concluded a meeting lasting over three hours with Jeon Young-hyun, President and CEO of SamsungElectronics and Vice Chairman in charge of the Device Solutions (DS) …
Epfeglenatide, developed by HanmiPharm, has received approval from the Ministry of Food and Drug Safety as the first domestically developed GLP-1-based obesity treatment. With this approval, Korea has…
A new domestically developed drug has emerged to compete in the obesity treatment market, which is currently dominated by global pharmaceutical companies. With HanmiPharm’s efeglenatide receiving mark…
